IQVIA Holdings, Inc. is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.
IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA helps speed drug development, ensure product quality and safety, improve commercial effectiveness, get the right treatments to patients, improve access and delivery of healthcare, and ultimately drive better health outcomes through its Connected Intelligence™ approach.
(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)
Healthcare is a central component of our measure of Humankind Value, as a large contribution to modern life expectancies has come from the last 150 years of medical innovation. IQVIA Holdings, Inc. is responsible for positive Humankind Value, with much of its positive value coming from Healthcare R&D ($41.4 B), Pharmaceuticals ($19.0 B), and Economic Value ($5.3 B). Positive value from Healthcare R&D and Pharmaceuticals contains our estimation of 1,253,083.4 additional years lived by people worldwide. The company produces economic value by offering to consumers goods and services that they value, paying employees for their labor in producing these goods and services, and providing value for shareholders. The Humankind Value of this company can improve with reductions in Opioid Abuse (-$2.4 B). Economic Value is attached to this company as a result of its direct business activities. Healthcare R&D, Pharmaceuticals, and Opioid Abuse are mostly or entirely a result of supply-chain relationships. While this company has a positive Humankind Value when studied in isolation, consideration of supply chain interactions pushes its Humankind Value higher.